查爾斯河實驗室國際公司(Charles River Laboratories International, Inc.)從事提供產品和服務,以幫助製藥和生物技術公司。該公司的總部設在麻薩諸塞州威明頓,目前有18,600名全職員工。公司於2000年6月23日上市。公司提供關鍵產品和服務,幫助全球製藥和生物技術公司、政府機構和學術機構加速其研究和藥物開發工作。其研究模型與服務部門包括三個業務,提供實現客戶發現新分子的基礎工具:研究模型、研究模型服務和細胞解決方案。其發現與安全評估部門提供受監管和非受監管的發現與安全評估服務,支持潛在新藥的研究、開發和法規要求的安全測試,包括治療發現與優化,以及體外和體內研究、實驗室支持服務,還有策略性的非臨床諮詢和項目管理,以支持產品開發。其製造解決方案部門包括微生物解決方案和生物製品解決方案。
What is Charles River Laboratories International Inc (CRL)'s P/E Ratio?
The P/E ratio of Charles River Laboratories International Inc is 895.4568
Who is the CEO of Charles River Laboratories International Inc?
Mr. James Foster is the Chairman of the Board of Charles River Laboratories International Inc, joining the firm since 1976.
What is the price performance of CRL stock?
The current price of CRL is $290, it has 下降 0.49% in the last trading day.
What are the primary business themes or industries for Charles River Laboratories International Inc?
Charles River Laboratories International Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Charles River Laboratories International Inc market cap?
Charles River Laboratories International Inc's current market cap is $13.9B
Is Charles River Laboratories International Inc a buy, sell, or hold?
According to wall street analysts, 18 analysts have made analyst ratings for Charles River Laboratories International Inc, including 2 strong buy, 7 buy, 14 hold, 0 sell, and 2 strong sell